Lexaria Granted Two New Patents In Canada; Canadian Patent #2,984,917 And Canadian Patent #3,111,082
Portfolio Pulse from Benzinga Newsdesk
Lexaria has been granted two new patents in Canada, bringing its total to 37 worldwide. The patents cover innovations in delivering lipophilic active drugs and molecules in a water-based format, and infusing tobacco leaves directly with drugs or active molecules for potential applications such as treating nicotine addiction.
October 12, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
The granting of two new patents to Lexaria could potentially enhance its product offerings and open up new markets, such as treatments for nicotine addiction.
Patents provide Lexaria with exclusive rights to their innovations, potentially preventing competitors from copying their technology. This could lead to increased market share and revenues, positively impacting the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100